Cagrilintide
Description
A novel long-acting synthetic amylin analog investigated for its roles in satiation pathways, delayed gastric emptying, and synergistic weight-management signaling in metabolic research.
Available in 5mg–10mg vials, every lot is third-party tested for identity and purity, with certificates of analysis available on request. Vials arrive sealed and sterile, lyophilized for stability, and ship from our U.S. facility in 2–6 days.
For in vitro laboratory research use only. See the Technical Data tab below for the full mechanism and feature summary.
Cagrilintide from Wolf Research is a high-purity research-grade compound intended strictly for laboratory research use.
Cagrilintide (Cagrilintide (long-acting amylin analog)) is supplied as a research-grade compound for in vitro study of incretin and metabolic receptor signaling pathways. GLP-class research compounds are widely used in laboratory studies of glucose metabolism, appetite-related pathways, and receptor pharmacology.
Every lot of Cagrilintide is third-party tested for identity and purity, with certificates of analysis available on request. Supplied in sealed, sterile vials and shipped fast from our U.S. facility.
The products offered herein are intended exclusively for research purposes and must be utilized solely within in vitro environments (e.g., test tubes or laboratory settings) for the purposes of testing and experimentation. All information provided on this website is strictly for educational purposes and does not constitute legal or professional advice. It is imperative to acknowledge that the introduction of these products into humans or animals, in any capacity, is strictly prohibited by applicable laws and regulations. Violation of these regulations may result in legal repercussions. These products are intended solely for use by qualified, licensed professionals with the expertise to handle them safely and responsibly. Furthermore, it is important to note that these products are not classified as drugs, food, or cosmetics under any legal definitions. Any misbranding, misuse, or mislabeling of these products within these categories is expressly prohibited and may lead to further legal consequences. By adhering to these guidelines, you ensure compliance with all regulatory frameworks and contribute to the responsible conduct of scientific research.
Technical Data
| A novel long-acting synthetic amylin analog investigated for its roles in satiation pathways, delayed gastric emptying, and synergistic weight-management signaling in metabolic research. | |
|---|---|
| Key Benefits & Highlights | |
| Targeted Amylin Receptor Agonism | Mimics endogenous amylin to selectively engage calcitonin and amylin receptors, supporting research into metabolic regulation and appetite control. |
| Enhanced Satiation Signaling | Researched for its ability to delay gastric emptying and promote prolonged signals of fullness in cellular and physiological models. |
| Synergistic Combination Potential | Widely studied alongside incretin mimetics (such as GLP-1 receptor agonists) for potential additive or synergistic effects on body weight regulation. |
| High Chemical Purity | Synthesized to stringent laboratory standards to ensure accurate peptide sequence fidelity and minimal experimental interference. |
| Standardized Research Reagent | Formulated for reliable reproducibility across in vitro assays, receptor binding studies, and metabolic pathway research. |
| Feature Summary | |
| Product Class | Synthetic Amylin Analog / Non-Incretin Peptide |
| Primary Application | In vitro satiety, gastric emptying & metabolic research |
| Grade | Laboratory / Research Grade Only |